CM
MEDP icon

Castleark Management’s Medpace MEDP Stock Holding History

Castleark Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,030
Closed -$4.82M – 335
2026
Q1 		$4.82M Sell
10,030
-92
-0.9% -$47.1K 0.16% 150
2025
Q4 		$5.69M Buy
10,122
+1,080
+12% +$613K 0.17% 145
2025
Q3 		$4.65M Buy
+9,042
New +$3.95M 0.13% 150
2025
Q2 		– Sell
-17,100
Closed -$5.21M – 318
2025
Q1 		$5.21M Buy
+17,100
New +$5.75M 0.18% 118
2024
Q4 		– Sell
-1,040
Closed -$347K – 314
2024
Q3 		$347K Sell
1,040
-23,530
-96% -$8.94M 0.01% 224
2024
Q2 		$10.1M Sell
24,570
-210
-0.8% -$83.2K 0.41% 40
2024
Q1 		$10M Sell
24,780
-3,330
-12% -$1.17M 0.42% 41
2023
Q4 		$8.62M Buy
28,110
+2,330
+9% +$629K 0.38% 50
2023
Q3 		$6.24M Buy
25,780
+13,800
+115% +$3.53M 0.32% 62
2023
Q2 		$2.88M Sell
11,980
-110
-0.9% -$22.8K 0.13% 153
2023
Q1 		$2.27M Buy
+12,090
New +$2.5M 0.11% 156
2022
Q1 		– Sell
-44,540
Closed -$9.69M – 345
2021
Q4 		$9.69M Buy
+44,540
New +$9.33M 0.36% 73
2021
Q1 		– Sell
-50,276
Closed -$7M – 356
2020
Q4 		$7M Sell
50,276
-37,725
-43% -$4.75M 0.26% 105
2020
Q3 		$9.83M Buy
+88,001
New +$10.2M 0.39% 71

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Castleark Management's MEDP Position: Q2 2026 in Review

Castleark Management sold out of Medpace (MEDP) in Q2 2026, closing a stake of 10,030 shares — an estimated $4.82M sold.

Castleark Management first reported a position in MEDP in Q3 2020 and held it in 14 quarters. The position peaked at $10.1M in Q2 2024. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Castleark Management reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Castleark Management sold 10,030 Medpace shares in Q2 2026, an estimated $4.82M.
  • Castleark Management first reported a position in Medpace in Q3 2020 and held it in 14 quarters.
  • Castleark Management's Medpace position peaked at $10.1M in Q2 2024.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Castleark Management's 13F filing for Q2 2026, filed 14 Aug 2026.